These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 24975463)

  • 1. Serum fetuin-A concentration predicts glycaemic outcomes in people with prediabetes: a prospective study from eastern India.
    Dutta D; Mondal SA; Kumar M; Hasanoor Reza AH; Biswas D; Singh P; Chakrabarti S; Mukhopadhyay S
    Diabet Med; 2014 Dec; 31(12):1594-9. PubMed ID: 24975463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes.
    Calanna S; Scicali R; Di Pino A; Knop FK; Piro S; Rabuazzo AM; Purrello F
    Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):670-6. PubMed ID: 24656139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary albumin : creatinine ratio predicts prediabetes progression to diabetes and reversal to normoglycemia: role of associated insulin resistance, inflammatory cytokines and low vitamin D.
    Dutta D; Choudhuri S; Mondal SA; Mukherjee S; Chowdhury S
    J Diabetes; 2014 Jul; 6(4):316-22. PubMed ID: 24251376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
    Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
    Cuthbertson DJ; Koskinen J; Brown E; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
    Ann Med; 2021 Dec; 53(1):1256-1264. PubMed ID: 34309471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study.
    Ming J; Xu S; Gao B; Liu G; Ji Y; Yang F; Jia Y; Fang Y; Ji Q
    Liver Int; 2015 Nov; 35(11):2401-7. PubMed ID: 25879672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study.
    Ligthart S; van Herpt TT; Leening MJ; Kavousi M; Hofman A; Stricker BH; van Hoek M; Sijbrands EJ; Franco OH; Dehghan A
    Lancet Diabetes Endocrinol; 2016 Jan; 4(1):44-51. PubMed ID: 26575606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease.
    Celebi G; Genc H; Gurel H; Sertoglu E; Kara M; Tapan S; Acikel C; Karslioglu Y; Ercin CN; Dogru T
    Saudi J Gastroenterol; 2015; 21(3):139-45. PubMed ID: 26021772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort study.
    Vistisen D; Kivimäki M; Perreault L; Hulman A; Witte DR; Brunner EJ; Tabák A; Jørgensen ME; Færch K
    Diabetologia; 2019 Aug; 62(8):1385-1390. PubMed ID: 31123789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study.
    Carlsson LMS; Sjöholm K; Karlsson C; Jacobson P; Andersson-Assarsson JC; Svensson PA; Larsson I; Hjorth S; Neovius M; Taube M; Carlsson B; Peltonen M
    Lancet Diabetes Endocrinol; 2017 Apr; 5(4):271-279. PubMed ID: 28237791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and validation of plasma, saliva and multi-fluid plasma-saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults.
    Haslam DE; Liang L; Guo K; Martínez-Lozano M; Pérez CM; Lee CH; Morou-Bermudez E; Clish C; Wong DTW; Manson JE; Hu FB; Stampfer MJ; Joshipura K; Bhupathiraju SN
    Diabetologia; 2024 Sep; 67(9):1838-1852. PubMed ID: 38772919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of prediabetes in older adults from a population-based longitudinal study.
    Shang Y; Marseglia A; Fratiglioni L; Welmer AK; Wang R; Wang HX; Xu W
    J Intern Med; 2019 Sep; 286(3):326-340. PubMed ID: 31165572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial.
    Moradi F; Kooshki F; Nokhostin F; Khoshbaten M; Bazyar H; Pourghassem Gargari B
    J Trace Elem Med Biol; 2021 Jan; 63():126659. PubMed ID: 33045675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study.
    Franch-Nadal J; Caballeria L; Mata-Cases M; Mauricio D; Giraldez-García C; Mancera J; Goday A; Mundet-Tudurí X; Regidor E;
    PLoS One; 2018; 13(6):e0198327. PubMed ID: 29856820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of serum fetuin-A levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography.
    Ballestri S; Meschiari E; Baldelli E; Musumeci FE; Romagnoli D; Trenti T; Zennaro RG; Lonardo A; Loria P
    Metab Syndr Relat Disord; 2013 Aug; 11(4):289-95. PubMed ID: 23600632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of NAFLD With Diabetes and the Impact of BMI Changes: A 5-Year Cohort Study Based on 18,507 Elderly.
    Liu M; Wang J; Zeng J; Cao X; He Y
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1309-1316. PubMed ID: 28324002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of serum fetuin-A levels with insulin resistance and vascular complications in patients with type 2 diabetes.
    Jung CH; Kim BY; Kim CH; Kang SK; Jung SH; Mok JO
    Diab Vasc Dis Res; 2013 Sep; 10(5):459-67. PubMed ID: 23811603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum preadipocyte factor 1 concentrations and risk of developing diabetes: a nested case-control study.
    Lee SH; Rhee M; Yang HK; Ha HS; Lee JH; Kwon HS; Park YM; Yim HW; Kang MI; Lee WC; Son HY; Yoon KH
    Diabet Med; 2016 May; 33(5):631-8. PubMed ID: 26220259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of an Indian diabetes prevention programme on association of adipokines and a hepatokine with incident diabetes.
    Susairaj P; Snehalatha C; Nanditha A; Satheesh K; Raghavan A; Vinitha R; Ramachandran A
    Sci Rep; 2021 Oct; 11(1):20327. PubMed ID: 34645898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study.
    Schmid V; Wagner R; Sailer C; Fritsche L; Kantartzis K; Peter A; Heni M; Häring HU; Stefan N; Fritsche A
    Diabetologia; 2017 Dec; 60(12):2341-2351. PubMed ID: 28840257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.